Safety and efficacy of cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP)

Autor:	P. Michele, R. Ratta, R. Iacovelli, M. Mancini, G. Fornarini, G. Facchini, G. Cartenì, M. Napolitano, G. Del Bene, D. Santini, M. Mariella Sorarù, M.G. Vitale, R. Ricotta, M. Tucci, S. Luzi Fedeli, M.G. Boe, A. Mecozzi, C. Ortega, C.N. Stemberg, G. Procopio
Rok vydání:	2017
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 28:vi18
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx423.003
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ecf7235ed607526eb7eb7685da9b05c1 https://doi.org/10.1093/annonc/mdx423.003 Zobrazit plný text záznamu